Drug Price Trends for FOLIVANE-F CAPSULE

Average Pharmacy Cost for FOLIVANE-F CAPSULE

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FOLIVANE-F CAPSULE	13811-0538-90	0.29613	EACH	2024-12-18
FOLIVANE-F CAPSULE	13811-0538-90	0.28854	EACH	2024-11-20
FOLIVANE-F CAPSULE	13811-0538-90	0.31656	EACH	2024-10-23
FOLIVANE-F CAPSULE	13811-0538-90	0.31118	EACH	2024-09-18
FOLIVANE-F CAPSULE	13811-0538-90	0.31268	EACH	2024-08-21

Market Analysis and Price Projections for Folivane-F Capsule

Introduction

Folivane-F is a professionally prescribed dietary supplement containing ferrous fumarate, iron, folic acid, ascorbic acid, and niacin. It is designed to improve the nutritional status of patients with iron and/or folate deficiency anemia, particularly in prenatal and postnatal women. Here, we will delve into the market analysis and price projections for Folivane-F capsules.

Market Drivers

The market for Folivane-F and similar supplements is driven by several key factors:

Increasing Health Consciousness

There is a growing trend towards health consciousness among consumers, leading to an increased demand for dietary supplements and medications that cater to specific health needs. This trend is particularly evident in the rise of the nutraceuticals market, which includes products like Folivane-F[3].

Chronic Disease Management

The rising prevalence of chronic diseases and an aging population contribute to the demand for effective pharmaceutical and nutraceutical products. Folivane-F, with its combination of essential nutrients, is well-positioned to meet these needs[3].

Convenience and Bioavailability

Liquid-filled and softgel capsules, like those containing Folivane-F, offer enhanced bioavailability and quicker absorption compared to traditional solid forms. This convenience and effectiveness are significant drivers for the market[3].

Market Restraints

Despite the positive drivers, there are several restraints that could impact the market for Folivane-F:

High Production Costs

The manufacturing of liquid-filled capsules, including those containing Folivane-F, is associated with high production costs. This can limit accessibility for smaller manufacturers and startups, potentially constraining market growth[3].

Competition from Alternative Dosage Forms

The market also faces competition from alternative dosage forms such as tablets and powders, which may be perceived as more familiar or cost-effective by consumers[3].

Price Projections

The pricing of Folivane-F capsules can be influenced by several factors, including production costs, market demand, and competition.

Current Pricing

As of the current data, generic versions of Folivane-F (such as Integra F) are available at U.S. pharmacies starting at around $0.50 per capsule for a 30-capsule supply. This pricing is facilitated by discount programs and pharmacy benefit managers[5].

Future Pricing Trends

Given the growing demand for nutraceuticals and the increasing focus on personalized medicine, the prices of Folivane-F and similar products may remain competitive. Here are some potential trends:

• Stable Pricing: With the presence of generic alternatives and discount programs, the prices of Folivane-F capsules are likely to remain stable or see minimal increases.
• Cost Savings: The use of discount cards and pharmacy benefit managers can continue to provide significant savings for consumers, keeping the effective cost of the medication low[5].
• Market Competition: As more manufacturers enter the market with similar products, competition could drive prices down, making Folivane-F more affordable for a wider audience.

Target Market and End Users

Folivane-F is primarily targeted at patients with iron and/or folate deficiency anemia, including:

Prenatal and Postnatal Women

Women in the prenatal and postnatal periods are a key demographic due to the critical need for iron and folic acid during these phases[1][4].

Geriatric and Pediatric Populations

Although the safety and effectiveness of Folivane-F have not been established in pediatric and geriatric patients, there is potential for future research and expansion into these markets[1][4].

Distribution and Accessibility

Folivane-F is available through various channels, including:

Pharmacies

The medication is available at U.S. pharmacies, both in physical stores and through mail-order services. Discount programs and pharmacy benefit managers play a crucial role in making the medication more accessible[5].

Healthcare Providers

Folivane-F is prescribed by healthcare practitioners, ensuring that it reaches patients who need it most. This professional prescription route helps in maintaining the quality and safety of the product[1][4].

Technological Advancements

Technological advancements in capsule manufacturing, such as the development of moisture-resistant materials and improved encapsulation techniques, enhance the stability and efficacy of Folivane-F. These advancements are expected to continue, further supporting the market growth[3].

Emerging Trends

Several emerging trends are likely to influence the market for Folivane-F:

Natural and Plant-Based Formulations

There is a growing demand for clean-label products and sustainable ingredients. Manufacturers are increasingly focusing on research and development to create innovative formulations that meet these consumer preferences[3].

Personalized Medicine

The trend towards personalized medicine is expected to grow, with companies exploring customized capsules tailored to individual health profiles and dietary preferences. This could lead to more targeted and effective use of Folivane-F and similar products[3].

Key Takeaways

• Growing Demand: The market for Folivane-F is driven by increasing health consciousness and the need for effective nutritional supplements.
• Competitive Pricing: Prices are expected to remain competitive due to generic alternatives and discount programs.
• Technological Advancements: Improvements in capsule manufacturing will enhance product stability and efficacy.
• Emerging Trends: Natural formulations and personalized medicine are likely to shape the future market.

FAQs

Q: What are the primary ingredients in Folivane-F capsules? A: Folivane-F capsules contain ferrous fumarate, iron, folic acid, ascorbic acid, and niacin[1][4].

Q: Who is the target demographic for Folivane-F? A: The primary target demographic includes patients with iron and/or folate deficiency anemia, particularly prenatal and postnatal women[1][4].

Q: What are the potential side effects of Folivane-F? A: Common side effects include gastrointestinal disturbances such as anorexia, nausea, diarrhea, constipation, heartburn, and vomiting. Iron may also turn stools black, which is a harmless effect[1][4].

Q: How should Folivane-F be stored? A: Folivane-F should be stored beyond the reach of children to prevent accidental iron poisoning[1][4].

Q: Are there any contraindications for using Folivane-F? A: Yes, Folivane-F is contraindicated in patients with known hypersensitivity to any of the ingredients, hemosiderosis, hemochromatosis, hemolytic anemias, and pernicious anemia[1][4].

Cited Sources

1. DailyMed: FOLIVANE-F- ferrous fumarate, iron, folic acid, ascorbic acid, and niacin capsule[1].
2. UCare Medicare Group Formulary: 2024 UCare Medicare Group Formulary[2].
3. BusinessWire: Liquid Filled Capsule Market Analysis and Forecast, 2024-2034[3].
4. DailyMed: Folivane™-F with Ascorbic Acid Precursors[4].
5. PharmacyChecker: Folivane-F Prices - U.S. & International[5].